openPR Logo
Press release

Bioink Market is Set to Surge at 18.8% CAGR, to Reach US$ 1.03 Billion by 2034: Fact.MR Report

03-31-2025 09:33 AM CET | Health & Medicine

Press release from: Fact.MR

Bioink Market

Bioink Market

The size of the global bioink market is estimated at US$ 185.6 million in 2024, according to a new study released by Fact.MR. Global demand for bioinks is expected to grow at a prolific CAGR of 18.8% and reach a market value of US$ 1.03 billion through the end of 2034.

Continuous development in 3D printing technology is expected to drive growth in the sales of compatible bioinks in the future. Technology improvements facilitate the creation of more intricate, functional, and accurate organ and tissue printing, which requires manufacturing of specialized bioinks capable of replicating natural tissues.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9475

What is Driving Fast Global Bioink Market Growth?

"Rising Cases of Organ Failure Necessitating Production of 3D Printed Organs

Increased cases of organ failure due to various causes, such as accidents, burns, old age, and poor lifestyle, are expected to lead to growing demand for bioinks because of the increased demand for 3D-printed organs. The process of 3D printing is expected to assist in addressing the challenges of organ shortages worldwide. There is no real drug therapy available to reverse organ failure.

The Organ Procurement and Transplantation Network issued a report in 2021. According to the statistics presented via the report, around 180,000 patients suffer from renal failure every year and 6,000 renal transplants are conducted.

Country-wise Insights

North America is also predicted to have 56.9% market share in the world by 2034, according to the report by Fact.MR, a market research and competitive intelligence company. Growing adoption of 3D bioprinters and greater investments by firms to offer tissue-specific bioinks are expected to drive revenue streams in the future.

China is projected to hold a 46.6% share of the East Asian market in 2034. The Chinese government is actively striving to be self-reliant in the biopharma business. Enhancement of the Chinese biopharmaceutical business is one of the priority areas for the government in China. Apart from that, significant investments made by the government in biotech R&D exercises are projected to broaden opportunities for players.

Category-wise Insights

Worldwide demand for collagen-based bioinks is anticipated to grow immensely due to their improved compatibility and contribution towards the construction of fibrous networks for the human body. These trends in the bioink market are anticipated to create financially rewarding opportunities for players in the future.

The collagen segment is anticipated to capture 19% of the world market by 2034. Collagen is employed as one of the major structural elements of tendon, bone, skin, and other connective tissues. The facile compatibility of collagen coupled with its capacity to create a fibrous network in the human body is expected to drive its uptake.

Browse Full Report: https://www.factmr.com/report/bioink-market

Competitive Landscape

Leading producers of bioinks are supplying technologically superior products. Besides, mergers & acquisitions to expand offerings are undertaken by them. Moreover, quality control of products, supply chain management, and R&D are expected to assist these players in achieving a competitive advantage.

For example :

CollPlant introduced Collink.3DTM to use in the 3D bioprinting of human organs, scaffolds, and tissues during November 2021.
BICO bought Advanced BioMatris in August 2021. The latter is specialized in 3D research applications and is America-based with a robust portfolio of collagen bioinks, chemically modified proteins, and other cell assays.

Some major players in the bioink market include Merck KGaA, CELLINK, BICO, CollPlant Biotechnologies Ltd., Humabiologics, Allevi, Inc., Black Drop Biodrucker Gmb, Foldink, UPM Biomedicals, Axolotl Biosciences, Manchester BIOGEL, TheWell Bioscience Inc., and 3DPL.

Segmentation of Bioink Market Research

By Material:
Agarose
Alginate
Chitosan
Collagen
Fibrinogen
Gelatin
Hyaluronic Acid
Graphene
Hydroxyapatite
Cell- & Tissue-derived ECM
Poly (Ethylene Glycol) Diacrylate (PEGDA)
By Source:
Natural
Synthetic
By Printing Modality:
Extrusion-based Bioprinting
Inkjet-based Bioprinting
Laser-based Bioprinting
By Application:
Tissue Engineering & Regenerative Medicines
Tissue Transplantation
Pharmaceuticals & High-throughput Screening
By Organ:
Human Ears
Kidneys
Liver
Heart
Skin
Cartilages
Bones
Stem Cells
Blood Vessels
Cancer Research
Lungs
Muscles
By End User:
Medical Device Manufacturers
Pharmaceutical Companies
Research & Academic Institutions
Contract Research Organizations
By Region:
North America
Europe
East Asia
Latin America
Middle East & Africa
South Asia & Oceania

Check out More Related Studies Published by Fact.MR:

Postpartum Hemorrhage (PPH) Treatment Devices Market
https://www.factmr.com/report/postpartum-hemorrhage-pph-treatment-devices-market

Breast Imaging Technologies Market
https://www.factmr.com/report/breast-imaging-technologies-market

Venipuncture Procedure Market
https://www.factmr.com/report/venipuncture-procedure-market

Dental Mirrors Market
https://www.factmr.com/report/dental-mirrors-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioink Market is Set to Surge at 18.8% CAGR, to Reach US$ 1.03 Billion by 2034: Fact.MR Report here

News-ID: 3946988 • Views:

More Releases from Fact.MR

European Switch Mode Power Supply Transformers Market Outlook 2025-2035: Innovation, Growth, and Demand Trends
European Switch Mode Power Supply Transformers Market Outlook 2025-2035: Innovat …
The global switch-mode power supply transformers market is set to grow substantially in the next decade, fueled by expanding demand for energy-efficient power electronics, increasing deployment of renewable energy systems, and rapid growth in consumer electronics. The market is projected to expand from USD 1.8 billion in 2025 to approximately USD 3.2 billion by 2035, representing a compound annual growth rate (CAGR) of about 6.2%. Key Market Highlights 2025 Market Value: USD
Uk Soy Leghemoglobin Industry Outlook 2025-2035: Innovation, Growth, and Demand Trends
11-20-2025 | Food & Beverage
Fact.MR
Uk Soy Leghemoglobin Industry Outlook 2025-2035: Innovation, Growth, and Demand …
The soy leghemoglobin ingredient market in the United Kingdom is emerging as a strategic frontier in the alternative-protein space. While global projections estimate the soy leghemoglobin market to grow rapidly over the next decade, the UK industry is navigating a complex landscape shaped by regulatory constraints, consumer sentiment, and strong potential for future adoption. Key Market Dynamics in the UK Soy leghemoglobin is an iron-rich, heme-bearing protein produced via precision fermentation in
European Sciatica Treatment Market Outlook 2025-2035: Key Developments and Future Scope
11-20-2025 | Health & Medicine
Fact.MR
European Sciatica Treatment Market Outlook 2025-2035: Key Developments and Futur …
The global sciatica treatment market is poised for substantial growth over the next decade as populations age, sedentary lifestyles proliferate, and non-opioid pain management solutions gain traction. Market value is expected to climb from USD 5.6 billion in 2025 to approximately USD 11.8 billion by 2035, reflecting a compound annual growth rate (CAGR) of around 7.7%. Key Market Highlights 2025 Market Size: USD 5.6 billion 2035 Forecast Value: USD 11.8 billion Projected CAGR (2025-2035):
European Soy Sauce Market Outlook 2025-2035: Key Developments and Future Scope
11-20-2025 | Food & Beverage
Fact.MR
European Soy Sauce Market Outlook 2025-2035: Key Developments and Future Scope
The global soy sauce market is poised for substantial growth over the next decade, driven by escalating demand for savory umami condiments, the expansion of Asian cuisine globally, and an increased focus on healthier, blended soy sauce options. The market is forecast to grow from USD 59.1 billion in 2025 to approximately USD 93.0 billion by 2035, achieving a compound annual growth rate (CAGR) of 4.6%. Key Market Highlights 2025 Market Size:

All 5 Releases


More Releases for Bioink

Bioink Market 2025 | Industry Developments, Future Growth, Share & Industry Insi …
bioink market size reached US$ 214.46 million in 2024 is expected to reach US$ 1,081.44 million by 2033, growing at a CAGR of 19.8% during the forecast period 2025-2033 DataM Intelligence has published a new research report on "Bioink Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this
Bioink Market to Reach USD 4.3 Billion by 2034
Bioinks are a crucial component of 3D bioprinting, a cutting-edge technology that uses living cells, biomaterials, and bioactive molecules to print biological tissues, organs, and medical devices. Bioinks enable the creation of functional tissue models, personalized medicine, and tissue regeneration, and are playing a vital role in advancing regenerative medicine and organ transplantation. As 3D bioprinting technology evolves, bioinks are becoming increasingly sophisticated, with advancements in their properties, compatibility with
Bioink Market Demand, High Growth Rate to Reach USD 687.96 Mn. by 2030
The Bioink Market was valued at USD 186.70 million in 2023, with projections indicating substantial growth in the coming years. The market is expected to expand at a CAGR of 20.48% from 2024 to 2030, reaching an estimated revenue of nearly USD 687.96 million by the end of the forecast period. This rapid growth is driven by advancements in bioprinting technology, increasing applications in regenerative medicine, and rising demand for customized
Bioink Manufacturing Plant Project Report 2024: Setup Details, Capital Investmen …
IMARC Group's report, titled "Bioink Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a complete roadmap for setting up a bioink manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the
Bioink Market Reach USD 687.96 Mn.: Growth Projections and Key Drivers
Anticipated Growth in Revenue: The Bioink Market size was valued at USD 186.70 Mn. in 2023 and the total revenue is expected to grow by 20.48% from 2024 to 2030, reaching nearly USD 687.96 Mn. Bioink Market Overview: The bioink system market is experiencing robust growth driven by advancements in 3D bioprinting technology and increasing applications in regenerative medicine and pharmaceutical research. Bioink systems play a crucial role in enabling the precise deposition
04-19-2024 | Health & Medicine
Fact.MR
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
In 2024, the global bioink market (バイオインク市場) is estimated at US$ 185.6 million. Forecasts project a remarkable Compound Annual Growth Rate (CAGR) of 18.8%, catapulting the demand for bioinks to reach a substantial market value of US$ 1.03 billion by 2034. Recent years have witnessed a consistent rise in the necessity for organ replacements and tissue regeneration. Innovations in these fields are anticipated to facilitate the transformation of damaged tissues into